Citation:
Abdelmoneim AS, Eurich DT, Gamble JM, Johnson JA, Seubert JM, Qiu W, et al. Diabetes, Obesity and Metabolism. Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: A nested case-control study [Internet]. 2014;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84890569821&partnerID=MN8TOARS